Search Results - "Goldfischer, Evan R"

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1‐year, open‐label extension study by Donatucci, Craig F., Brock, Gerald B., Goldfischer, Evan R., Pommerville, Peter J., Elion‐Mboussa, Albert, Kissel, Jay D., Viktrup, Lars

“…Study Type – Therapy (cohort)
Level of Evidence 2b What’s known on the subject? and What does the study add? Phosphodiesterase type‐5 (PDE5) inhibitors…”
Get full text

Clinical Research 2021 by Goldfischer, Evan R.

“…Clinical research is of great benefit to patients and rewarding to clinicians. Clinical research in the United States is highly regulated. There are…”
Get full text

Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies by Porst, Hartmut, Oelke, Matthias, Goldfischer, Evan R, Cox, David, Watts, Steven, Dey, Debashish, Viktrup, Lars

“…Objective To assess the efficacy and safety of tadalafil, a phosphodiesterase 5 (PDE5) inhibitor efficacious for erectile dysfunction and lower urinary tract…”
Get full text

Preparation and administration of androgen deprivation therapy products: Retrospective survey results by Goldfischer, Evan R., Grubb, ElizaBeth, Nisbet, Paul

“…Leuprolide acetate (LA) is a gonadotropin‐releasing hormone agonist used as androgen deprivation therapy for advanced prostate cancer. LA is available in…”
Get full text

Assessing the impact of ureteral stent design on patient comfort by Lingeman, James E, Preminger, Glenn M, Goldfischer, Evan R, Krambeck, Amy E

“…We assessed the near term comfort of newly designed ureteral study stents or marketed control stents, including Polaris and Percuflex stents. Study stents had…”
Get more information

Validation of the Decreased Sexual Desire Screener (DSDS): A Brief Diagnostic Instrument for Generalized Acquired Female Hypoactive Sexual Desire Disorder (HSDD) by Clayton, Anita H., Goldfischer, Evan R., Goldstein, Irwin, DeRogatis, Leonard, Lewis-D'Agostino, Diane J., Pyke, Robert

“…An accurate diagnosis of Hypoactive Sexual Desire Disorder (HSDD) currently relies on a time-consuming interview with an expert clinician. Limited access to…”
Get full text

Continued Efficacy and Safety of Flibanserin in Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD): Results from a Randomized Withdrawal Trial by Goldfischer, Evan R., Breaux, Jeffery, Katz, Molly, Kaufman, Joel, Smith, William B., Kimura, Toshio, Sand, Michael, Pyke, R.b.

“…Flibanserin is a 5‐HT1A agonist/5‐HT2A antagonist that has been shown to increase sexual desire and reduce distress in premenopausal women with Hypoactive…”
Get full text

Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: A randomized, double-blind, placebo-controlled study by Goldfischer, Evan R., Sand, Peter K., Thomas, Heather, Peters-Gee, Jill

“…Aims To assess the efficacy and safety of oxybutynin transdermal gel 3% (OTG3%), with propylene glycol for enhanced skin permeation, in patients with urinary…”
Get full text

Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer by Breul, Jürgen, Lundström, Eija, Purcea, Daniela, Venetz, Werner P., Cabri, Patrick, Dutailly, Pascale, Goldfischer, Evan R.

“…Introduction Androgen deprivation therapy (ADT) is a mainstay of treatment against advanced prostate cancer (PC). As a treatment goal, suppression of plasma…”
Get full text

A Return to Normal Erectile Function with Tadalafil Once Daily after an Incomplete Response to As‐Needed PDE5 Inhibitor Therapy by Kim, Edward D., Seftel, Allen D., Goldfischer, Evan R., Ni, Xiao, Burns, Patrick R.

“…An optimal outcome of an erectile dysfunction (ED) treatment is to enable a return to normal erectile function (as defined by an International Index of…”
Get full text

Impact of Low Testosterone on Response to Treatment With Tadalafil 5 mg Once Daily for Erectile Dysfunction by Goldfischer, Evan R, Kim, Edward D, Seftel, Allen D, Baygani, Simin K, Burns, Patrick R

“…Objective To evaluate, posthoc, the relationship between serum total testosterone and response to therapy in a study of tadalafil once daily for erectile…”
Get full text

Patient‐optimized doses of fesoterodine improve bladder symptoms in an open‐label, flexible‐dose study by Wyndaele, Jean‐Jacques, Goldfischer, Evan R., Morrow, Jon D., Gong, Jason, Tseng, Li‐Jung, Choo, Myung‐Soo

“…Study Type – Therapy (cohort) Level of Evidence 2b What’s known on the subject? and What does the study add? We know that bladder‐relaxing agents…”
Get full text

Preserving Independent Urology: LUGPA's First Decade by Shore, Neal D, Kapoor, Deepak A, Goldfischer, Evan R, Chaikin, David C, Walz, Earl L, Henderson, R Jonathan, Harris, Richard G, Asinof, Robert D, Kirsh, Gary M

Get full text

Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes by Kaplan, Steven A, Goldfischer, Evan R, Steers, William D, Gittelman, Marc, Andoh, Masakazu, Forero-Schwanhaeuser, Sergio

“…In the few studies to evaluate antimuscarinics for overactive bladder (OAB) in men, safety has been the primary focus. In OAB efficacy trials, subject…”
Get more information

Changes in urine volume accomplished by physicians treating nephrolithiasis by Parks, Joan H, Goldfischer, Evan R, Coe, Frederic L

“…We quantified the changes in urine volume and sodium accomplished in various practice settings and the consequent effects on calcium oxalate supersaturation…”
Get more information

Complete renal embolization as an alternative to nephrectomy by Hom, D, Eiley, D, Lumerman, J H, Siegel, D N, Goldfischer, E R, Smith, A D

“…Simple nephrectomy is technically demanding in patients with recurrent inflammation or bleeding. It is also unwise to subject patients in poor health to the…”
Get more information

Randomized, prospective, double-blind study of the effects on pain perception of lidocaine jelly versus plain lubricant during outpatient rigid cystoscopy by Goldfischer, E R, Cromie, W J, Karrison, T G, Naszkiewicz, L, Gerber, G S

“…There is no clear evidence that intraurethral lidocaine jelly decreases pain and/or makes rigid cystoscopy more tolerable for patients. Since lidocaine jelly…”
Get more information

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION) by Prasad, Sandip M, Shishkov, Dimitar, Mihaylov, Nikola Vladimirov, Khuskivadze, Alexandre, Genov, Pencho, Terzi, Vasyl, Kates, Max, Huang, William C, Louie, Michael J, Raju, Sunil, Burger, Brent, Meads, Andrew, Schoenberg, Mark

“…To evaluate the efficacy and safety of UGN-102 chemoablation for the primary treatment of patients with recurrent low-grade intermediate-risk…”
Get full text

Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: A randomized, double-blind, placebo-controlled study: Oxybutynin Gel 3% vs. Placebo for UI Symptoms by Goldfischer, Evan R., Sand, Peter K., Thomas, Heather, Peters-Gee, Jill

Get full text

Transurethral Microwave Thermotherapy for Management of Benign Prostatic Hyperplasia: A Single-Institution Experience by Stravodimos, Konstantinos G, Goldfischer, Evan R, Klima, Wlodek J, Jabbour, Michel E, Smith, Arthur D

“…Objectives. This is the first and largest single institution retrospective study in the United States to examine the effects of transurethral microwave…”
Get full text